Neuland Laboratories Ltd. Industry : (Pharmaceuticals)

Quick Glance
Listed on BSE and NSE
  • Market Cap 643Crores
  • Book Value 544
  • Face Value 10
  • Current Price 501.30
  • % Change -2.67
  • 52 week H/L 825/ 431
  • Stock P/E 39.12
  • Dividend Yield 0 %

Stock vs. Index

Neulnd Labs
Sensex

Historical Return

1 Yr (%) 2 Yr (%) 3 Yr (%) 4 Yr (%) 5 Yr (%)
-12.96 -62.54 -48.07 2.79 48.77

ROCE Vs RONW

ROCE
RONW

Price History


  • Start Date :
  • End Date :

You can view historic prices (Open,High,Low,Close) of the company for the range of days


Shareholding Pattern

collapse Financial Performance collapse

Quarterly Results

(All figures In Rs. Cr.) Jun 17 Sep 17 Dec 17 Mar 18 Jun 18 Sep 18 Dec 18 Mar 19
Sales 115.75 125.85 115.93 160.23 153.96 168.74 171.47 172.66
Other Income 2.66 0.34 1.35 0.29 1.11 0.64 0.41 1.33
Operating Profit 10.64 14.36 9.88 18.79 8.98 14.65 15.84 18.40
Interest 4.77 5.23 4.81 4.88 3.88 4.07 3.00 4.71
Depreciation 5.10 5.38 5.54 5.61 5.66 5.92 7.35 6.93
Taxation 1.13 1.49 -0.32 0.54 0.14 0.90 1.30 1.36
Net Profit / Loss 2.30 2.59 1.21 8.05 0.41 4.40 4.60 6.73

Annual Results

(All figures In Rs. Cr.) Mar 11 Mar 12 Mar 13 Mar 14 Mar 15 Mar 16 Mar 17 Mar 18 Mar 19
Sales 397.81 449.93 463.90 469.11 464.70 509.97 572.74 527.41 666.83
Other Income 0.00 0.00 0.00 0.00 5.23 1.62 0.93 4.53 3.49
Operating Profit 48.51 48.35 61.45 76.35 61.92 79.87 87.45 50.03 57.87
Interest 29.84 33.27 31.33 23.64 27.35 24.47 20.85 18.92 15.66
Depreciation 15.41 14.89 14.62 14.94 15.32 15.74 18.65 22.10 25.86
Taxation 0.02 -1.85 1.86 7.56 8.70 14.87 15.08 1.73 3.69
Net Profit / Loss 5.07 2.03 13.64 26.67 15.78 26.41 32.43 11.81 16.14

Compounded Sales & Net Profit Growth

Period Sales % Net Profit %
TTM -22.36% -12.33%
1 Years 0.95% 69.01%
2 Years -4.09% 0.49%
3 Years -6.44% -6.31%
4 Years -2.89% 22.59%
5 Years -6.79% 10.57%

Investor Returns

Type Ratio / % Date
Dividend
12.00
27 Jun 2019
Rights
4:25
13 Aug 2014

Announcements

Date Title
Jul 17, 2019 Neuland Laborat - Press Release
Jul 16, 2019 Neuland Laborat - Board Meeting Intimation for To Consider And Approve The In-Audited Financial Results For The Quarter Ended
Jul 15, 2019 Neuland Laborat has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2019
Feb 13, 2019 Neuland Labs zooms 20 per cent post Q3 results
collapse Peer Review collapse

Peer Companies

Company CMP (Rs.) % Change Market Cap (Rs. Cr.) 52 Week H/L Book Value (Rs.) PE (x)
1 2 3 4 5 >
Sun Pharmaceutical Industries Ltd.
421.55
-1.08%
101,143.97
678.80 / 350.40
172.59
37.95
Dr. Reddy's Laboratories Ltd.
2,619.00
-1.17%
43,505.21
2,965.20 / 2,017.20
844.22
22.31
Cipla Ltd.
537.00
-1.84%
43,276.19
678.00 / 483.75
186.28
28.33
Divi's Laboratories Ltd.
1,618.05
-1.43%
42,954.14
1,769.00 / 1,068.10
262.07
31.75
Piramal Enterprises Ltd.
1,904.40
-3.92%
37,868.34
3,302.55 / 1,706.10
1,370.70
25.71
Lupin Ltd.
747.10
-1.18%
33,813.06
986.00 / 697.30
303.64
55.75
Aurobindo Pharma Ltd.
552.30
-3.10%
32,360.12
838.00 / 549.85
237.08
13.68
Biocon Ltd.
240.35
-8.79%
28,842.00
359.18 / 230.00
50.82
31.86
Torrent Pharmaceuticals Ltd.
1,516.00
-1.88%
25,654.16
1,964.00 / 1,407.45
279.18
58.80
Cadila Healthcare Ltd.
228.45
-1.10%
23,387.06
432.40 / 223.20
101.46
12.65